Table
4: Distribution
of cases according to PMS and SMS and their immunoreactive
features**.
|
|
PAX8 |
WT1 |
CD56 |
Ber-EP4 |
ER |
Total |
||||||
|
PMS |
13
(37.1%) |
0
(0) |
2
(5.7%) |
32
(91.4%) |
29
(82.9%) |
35
(100%) |
||||||
|
EEC |
13 |
41.9% |
0 |
0% |
2 |
6.5% |
28 |
90.3% |
26 |
83.9% |
31 |
88.6% |
|
ESC |
0 |
0% |
0 |
0% |
0 |
0% |
4 |
100% |
3 |
75% |
4 |
11.4% |
|
SMS |
26
(74.3%) |
28
(80%) |
11
(31.4%) |
26
(74.3%) |
25
(71.4%) |
35
(100%) |
||||||
|
TSC |
5 |
62.5% |
7 |
87.5% |
3 |
37.5% |
6 |
75% |
5 |
62.5% |
8 |
22.9% |
|
OSC |
18 |
90% |
18 |
90% |
8 |
40% |
17 |
85% |
17 |
85% |
20 |
57.1% |
|
PSC |
2 |
66.7% |
1 |
33.3% |
0 |
0% |
3 |
100% |
3 |
100% |
3 |
8.6% |
|
PMM |
1 |
25% |
2 |
50% |
0 |
0% |
0 |
0% |
0 |
0% |
4 |
11.4% |
|
Total |
39
(55.7%) |
28
(40%) |
13
(18.6%) |
58
(82.9%) |
54
(77.1%) |
70
(100%) |
||||||
|
Result |
X2
= 9.78 |
X2
= 46.66 |
X2
= 7.65 |
X2
= 3.62 |
X2
= 1.29 |
|
||||||
|
*p
= 0.002 |
*p
= 0.001 |
*p
= 0.006 |
p
= 0.057 |
p
= 0.255 |
||||||||
*significant if p < 0.05; **None of the tumors react with desmin.